CSBR icon

Champions Oncology
CSBR

Overview Fund Activity

29 hedge funds and large institutions have $26.5M invested in Champions Oncology in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.

Holders
29
Holders Change
-3
Holders Change %
-9.38%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
1
Increased
9
Reduced
8
Closed
3
Calls
$20K
Puts
$25K
Net Calls
-$5K
Net Calls Change
-$1.72M

Top Buyers

1
TAM
1
Tocqueville Asset Management
New York
$2.77M
2
Millennium Management
2
Millennium Management
New York
$267K
3
HighTower Advisors
3
HighTower Advisors
Illinois
$141K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$227K
5
TRCT
5
Tower Research Capital (TRC)
New York
$9K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$307K
2
MAG
2
Millrace Asset Group
Pennsylvania
$875K
3
E
3
Ergoteles
New York
$0
4
AC
4
Aristides Capital
Kentucky
$97.5K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$604K
Name Holding Trade Value Shares
Change 		Shares
Change %
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$550 – – –
Wells Fargo
27
Wells Fargo
California
$189 +$5 +1 +2%
E
28
Ergoteles
New York
– -$105K -13,937 Closed
Barclays
29
Barclays
United Kingdom
– -$10K -1,342 Closed
1
2